| Trial ID: | L1601 |
| Source ID: | NCT03357874
|
| Associated Drug: |
Clopidogrel
|
| Title: |
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
|
| Acronym: |
TROUPER
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Coronary Syndrome
|
| Interventions: |
DRUG: Clopidogrel|DRUG: Ticagrelor
|
| Outcome Measures: |
Primary: the rate of major adverse cardiovascular events, 12 MONTHS | Secondary: the rate of bleedings, using the Bleeding Academic Research Consortium classification ≥3 defined at discharge, 1 MONTH AND 12MONTHS|the rate of myocardial infarction at discharge, 1 MONTH AND 12MONTHS|the rate of cardiovascular death at discharge, 1MONTH AND 12 MONTHS|the rate of urgent revascularization at discharge, 1MONTH AND 12 MONTHS|the rate of all-cause death at discharge, 1MONTH AND 12 MONTHS|the rate of hospital re-admission, 1MONTH AND 12 MONTHS|the rate of probable and definite stent thrombosis (ARC definition) at discharge, 1MONTH AND 12 MONTHS
|
| Sponsor/Collaborators: |
Sponsor: Assistance Publique Hopitaux De Marseille
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
514
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-10-28
|
| Completion Date: |
2023-08
|
| Results First Posted: |
|
| Last Update Posted: |
2021-01-22
|
| Locations: |
APHM, Marseille, 13354, France
|
| URL: |
https://clinicaltrials.gov/show/NCT03357874
|
